The transcription factor NF-kB is a positive transcription factor for a number of genes and has been recognized as an anti-apoptotic regulator. However, the mechanism by which NF-kB blocks apoptosis is still controversial. Here, we demonstrate the evidence that NF-kB could attenuate the TNF-a-induced apoptosis without de novo protein synthesis using human pancreatic cancer cell lines, MIA PaCa-2 and Capan-2. The TNF-a-induced apoptosis was blocked by IL-1b, a potent inducer of NF-kB activation. This inhibitory eect of IL-1b was evident when cells were treated with protein synthesis inhibitors such as cycloheximide (CHX). Moreover, NF-kB decoy oligonucleotides could not block the anti-apoptotic eect of IL-1b at doses sucient to block the NF-kB-dependent transcription induced by IL-1b. To con®rm the role of NF-kB in blocking apoptosis, we generated stable cell lines expressing IkBDN, a highly stable form of IkBa, a cytoplasmic inhibitor of NF-kB. In these stable transfectants, the antiapoptotic eect of IL-1b was totally abolished, indicating that the anti-apoptotic action of IL-1b could be ascribed to the NF-kB action. These ®ndings show that de novo protein synthesis is dispensable for anti-apoptotic eects of NF-kB and support the possibility that NF-kB could exert its anti-apoptotic action through protein-protein interaction.
Introduction
Cellular apoptotic mechanism has been recognized to be of fundamental importance in carcinogenesis as well as normal cell growth and dierentiation. Genetic loss or functional aberration of cellular control mechanism of apoptosis is considered to be a critical event in the initiation, promotion, or progression of cancer (Thompson, 1995; Gilmore et al., 1996) . For example, genetic alterations of pro-apoptotic genes such as p53 (Pfeifer and Holmquist, 1997) and anti-apoptotic genes such as bcl-2 (Read, 1997) can lead to carcinogenesis. In addition to these ®ndings, nuclear factor kappa B (NF-kB) has been implicated in carcinogenesis since some of the tumor promoter compounds, phorbol esters and okadaic acid can also induce NF-kB activation (Fujiki and Sugiura, 1987; Suganuma et al., 1988) . In fact, constitutive NF-kB activation has been observed in some malignant cells (Visconti et al., 1997; Krappmann et al., 1999) . Moreover, pro-in¯ammatory cytokines including TNF-a and IL-1b, physiological inducers of NF-kB, have also been shown to promote transformation of cells (Komori et al., 1993; Suganuma et al., 1996) .
NF-kB encompasses a family of inducible transcription factors and plays a critical role in the regulation of gene expression in response to various environmental challenges including in¯ammatory stimuli, infectious agents, and oxidative stress Baeuerle, 1998; Okamoto et al., 1997) . The NF-kB/Rel family is composed of p50, p65 (RelA), p52, RelB and c-Rel. The NF-kB heterodimer is composed of p50 and p65 with the p65 subunit responsible for transcriptional activation. NF-kB is normally retained as an inactive form in the cytoplasm through interaction with IkB family proteins. The anti-apoptotic nature of NF-kB has been demonstrated in RelA knockout mice where massive apoptosis of liver cells was noted (Beg et al., 1995) . The TNF-a treatment of RelA-de®cient (RelA/ 7/7) mouse embryo ®broblasts and macrophages caused cell death, whereas RelA+/+ cells were not killed by TNF-a (Beg and Baltimore, 1996) . Similarly, overexpression of a dominant negative IkBa in various cell lines enhanced the apoptotic killing induced by TNF-a, ionizing radiation, or genotoxic compounds (Wang et al., 1996; Van Antwerp et al., 1996) . It is still not clear whether the anti-apoptotic actions of NF-kB are through induction of anti-apoptotic factors such as c-IAP2 (Chu et al., 1997; Wang et al., 1998; Wu et al., 1998) or through direct interaction with a proapoptotic factor Mori et al., 2000) .
Here we demonstrate that the preceding NF-kB activation by IL-1b could endow cells with resistance to the TNF-a-induced apoptosis immediately (within 30 min) and even in the absence of de novo protein synthesis. We con®rmed that this anti-apoptotic action of IL-1b was exerted through the activated form of NF-kB using stable cell clones expressing a highly stable form of IkBa.
Results

Induction of apoptosis by TNF-a and attenuation of apoptosis by pretreatment with IL-1b
To examine whether TNF-a could induce apoptosis in MIA PaCa-2 cells, the cell culture was stimulated with TNF-a for 4 h. Apoptotic cells were evaluated by the nuclear morphology observed with Hoechst-33258 staining under a¯uorescence microscopy. Typical characteristics seen with apoptosis, such as nuclear condensation and fragmentation, were observed upon treatment of MIA PaCa-2 cells with TNF-a ( Figure  1a ). Quantitation of apoptosis was carried out by FACS analysis. The results showed a dose-dependent induction of apoptosis with 7.8%, 25% and 32% of cells undergoing apoptosis at 1.0, 10, and 100 ng/ml of TNF-a, respectively, as compared to the control (2.2% in the absence of TNF-a) (Figure 1b, c) . In contrast, when cells were pretreated with 20 ng/ml IL-1b, a potent inducer of NF-kB activation, 2 h before the stimulation with TNF-a, signi®cant reduction of the TNF-a-mediated apoptosis was observed.
Augmentation of apoptosis in cells stably expressing IkBDN
In order to examine whether this anti-apoptotic action of IL-1b is due to the NF-kB activation, we transduced MIA PaCa-2 cells with IkBDN, a highly stable form of IkB. MIA PaCa-2 cells were stably transfected with the pcDNA3.1IkBDN plasmid expressing IkBDN lacking the N-terminal 36 amino acids and known to be resistant to phosphorylation and degradation (Brockman et al., 1995) . As demonstrated in Figure 2a , These MIA PaCa-2 clones were further examined for their susceptibility to the anti-apoptotic eect of IL-1b. As shown in Figure 2c (top) and Figure 2d , MDN5 and MDN7 cells became signi®cantly sensitive to the pro-apoptotic eect of TNF-a even at its lower doses. Moreover, the IL-1b pretreatment could not block the TNF-a-induced apoptosis in both MDN5 and MDN7 cells (data not shown). Thus, we concluded that the anti-apoptotic action of IL-1b was due to the NF-kB activation in MIA PaCa-2 cells.
Anti-apoptotic actions of NF-kB do not necessarily require de novo protein synthesis Next, we examined whether de novo protein synthesis is required for the anti-apoptotic action of NF-kB. First, we determined the critical interval period between the IL-1b pretreatment and the TNF-a stimulation. In Figure 3a , cells were pretreated by IL-1b and subsequently stimulated by TNF-a for apoptosis induction with various interval periods, and the extents of suppression of apoptosis were compared. The pretreatment of cells by IL-1b 30 min before the TNF-a stimulation was found to be sucient for NFkB activation but not for de novo gene induction and protein production (Sakurada et al., 1996) . Furthermore, it was also observed that the TNF-a-mediated apoptosis was signi®cantly suppressed at this time interval. No dramatic increase in the anti-apoptotic eect was observed when the interval period was prolonged for up to 24 h.
To further verify these observations, we treated cells with a protein synthesis inhibitor CHX (5.0 mg/ml) before the IL-1b pretreatment and then compared the extents of the TNF-a-induced apoptosis. At this concentration of CHX, it was sucient to block de novo protein synthesis as examined by the level of transient expression of luciferase induced by IL-1b or TNF-a (Figure 3b ). Measurement of [ 3 H]leucine incorporation also con®rmed the suppression of whole protein synthesis by CHX (data not shown). As shown in Figure 3c , the synthesis of cellular proteins detected by 35 S-methionine labeling was generally suppressed by 5.0 mg/ml CHX. No speci®c protein induction or reduction was observed during 2 h treatment following stimulation by IL-1b.
When cells were treated with CHX, a slightly greater extent of apoptosis was observed when TNF-a was added (Figure 3d ). However, CHX could not abolish the anti-apoptotic eect of IL-1b. IL-1b pretreatment reduced the TNF-a-induced apoptosis from 54.2+3.4% to 34.0+4.0% and in the presence of CHX it reduced the apoptosis from 61.9+1.1% to 41.0+3.4% (the extents of the anti-apoptotic action of Figure 3 Attenuation of TNF-a-induced cell death by IL-1b pretreatment under protein synthesis inhibition. (a) Appearance of anti-apoptotic eects by IL-1b (20 ng/ml) with various interval periods before the TNF-a treatment (100 ng/ml). After 4 h of TNF-a treatment cells were analysed by FACScan as described in Materials and methods. MIA PaCa-2 cells were treated by IL-1b for the indicated hours (0 ± 24 h) preceding the TNF-a treatment (for 4 h). The suppression rate of apoptosis was calculated according to the following formula: suppression of apoptosis (%)=(A7B)/(A7C)6100, where A, B, C were the number of cells undergoing apoptosis with TNF-a treatment alone for 4 h, with both IL-1b and TNF-a treatments, and without IL-1b or TNF-a (background death), respectively. Mean percentage of 10 000 events was measured in each experiment. Data points, average of three independent measures; bars, SD. (b) Inhibition of de novo protein synthesis by CHX. MIA PaCa-2 cells were transfected with an NF-kB-driven luciferase reporter plasmid (pGL3-4kBwt-Luc). After 40 h of transfection, CHX (5.0 mg/ml) was added to the cell culture 1 h before addition of TNF-a (1 ng/ ml) or IL-1b (20 ng/ml). After 24 h of the cytokine treatment cells were collected and the luciferase activity was measured with a ®xed number of transfected cells. Data represent the mean of triplicate experiments; bars, SD. (c) Eects of IL-1b and CHX on de novo synthesis of cellular proteins. After 1 h incubation with CHX (5.0 mg/ml) MIA PaCa-2 cells were treated with or without IL-1b (20 ng/ml) and labeled with 125 mCi of 35 S-methionine for 2 h. Radio-labeled proteins were analysed on 10% SDS ± PAGE. (d) Eects of IL-1b pretreatment on the TNF-a-induced apoptosis in the presence of CHX. Similar concentrations of TNF-a and IL1b were used as in a. CHX (5.0 mg/ml) was added 1 h before addition of IL-1b. TNF-a was added after 2 h of IL-1 stimulation. Apoptotic MIAPaCa-2 cells were determined by FACScan. Data are means of ®ve independent experiments; bars, SD (n=5). For Capan-2 cells, apoptosis was quantitated by Hoechst-33258 staining upon¯uorescent microscopic examination. Data are means of three independent experiments; bars, SD (n=3) preceding NF-kB activation by IL-1b were 37.2% and 33.8%, respectively). We did not observe any cytotoxicity when cells were treated solely with CHX for up to 24 h. We also performed a similar experiment with another pancreatic cancer cell line, Capan-2 ( Figure  3d ). Capan-2 cells were relatively resistant to the proapoptotic action of TNF-a as compared with MIA PaCa-2, and CHX pretreatment augmented the TNFa-induced apoptosis. We then examined the eect of IL-1b in the presence of CHX. Even in the presence of CHX, the IL-1b treatment could block the TNF-ainduced apoptosis. Similarly, addition of another protein synthesis inhibitor geneticin (G418) (800 mg/ ml) 1 h before IL-1b did not signi®cantly block the anti-apoptotic eect (anti-apoptotic eects by IL-1b pretreatment was 34.7%, which was comparable to the eect of CHX) (data not shown).
NF-kB decoy did not affect the anti-apoptotic effect of IL-1b
We then asked whether the anti-apoptotic action of NF-kB can be inhibited by blocking its transcriptional activity using the NF-kB decoy (Morishita et al., 1997) . We ®rst con®rmed the ecacy of NF-kB decoy in inhibiting the NF-kB-dependent transcription. As shown in Figure 4a , the NF-kB-dependent transcription induced by IL-1b could be inhibited by the addition of the NF-kB decoy in a dose-dependent manner and almost complete inhibition was obtained at 1.0 mM of NF-kB decoy. We then examined the eect of NF-kB decoy on the anti-apoptotic action of IL-1b. As demonstrated in Figure 4b , the antiapoptotic action of IL-1b was evident even in the presence of NF-kB decoy. On the other hand, TNF-ainduced cell death in MIA PaCa-2 cells reduced from 47 to 29% by the pretreatment with IL-1b in the presence of NF-kB decoy.
Abolishment of anti-apoptotic effects of NF-kB in the stable cell lines expressing IkBDN
We then asked whether this anti-apoptotic action of IL-1b pretreatment, in the absence of de novo protein synthesis, requires active NF-kB and, if so, IkBDN can block this action. In Figure 5 , a stable MIA PaCa-2 cell line expressing IkBDN (MDN5) was treated with a lethal dose of TNF-a in the presence of CHX. Whereas the pretreatment with IL-1b could eciently block apoptosis in the control transformant stably transfected with the vector alone (ME1) and parental MIA PaCa-2, this anti-apoptotic eect of IL-1b was totally abolished in MDN5 cells. We also examined another stable transfectant IkBDN, MDN7, and the same results were obtained (data not shown). These observations have con®rmed that the anti-apoptotic action of IL-1b is mediated by NF-kB without involving de novo protein synthesis.
Discussion
We have demonstrated that NF-kB activation could block the TNF-a-induced apoptosis without requiring de novo protein synthesis in pancreatic cancer cell lines, MIA PaCa-2 and Capan-2. Previous studies have revealed the anti-apoptotic actions of NF-kB particularly of its trans-activating subunit p65 (RelA). These observations have further highlighted the role of NFkB in carcinogenesis and cancer therapy. For example, Wang et al. (1999) have recently demonstrated in a tumor implantation model using nude mice that inhibition of NF-kB through the adenoviral delivery of a dominant negative IkBa could sensitize tumors to TNF-a and a camptothecin derivative CPT-11. Since Figure 4 Eect of NF-kB decoy. (a) Inhibition of NF-kB activation by administration of the NF-kB decoy oligonucleotides. NF-kB decoy (denoted as`kB') and/or scrambled oligonucleotides (`scr') together with the NF-kB-driven luciferase reporter gene were transfected to MIA PaCa-2 cells. The concentration (mM) of each oligonucleotide was indicated. After the transfection, cells were stimulated with (+) or without (7) 20 ng/ml IL-1b for 20 h, collected by centrifugation, and lysed to measure luciferase activity. Data represent the average of triplicate measures; bars, SD. (b) Eects of NF-kB decoy on the anti-apoptotic action of IL-1b. MIA PaCa-2 cells were transfected with 1 mM NF-kB (kB) decoy or 1 mM scrambled oligonucleotides (sc). After 16 h of the decoy transfection, cells were treated by 100 ng/ml TNF-a for induction of apoptosis, ®xed and the number of apoptotic cells were counted by Hoechst-33258 staining. The rate of apoptotic cells, containing fragmented and/or condensed nuclei, were evaluated by counting about 1000 cells of random ®elds in each experiment. Data points, average of triplicated measures; bars, SD Inhibition of apoptosis by NF-kB S Kajino et al most of the reagents known to induce cancer cell apoptosis such as TNF-a, anti-cancer drugs and radiation also stimulate NF-kB, inhibition of NF-kB either by transduction of IkB or chemical inhibitors would be expected to enhance the cell-death inducing activity of these anti-cancer agents. There are at least two distinct mechanisms by which NF-kB blocks apoptosis: (1) induction of antiapoptotic factors including IEX-1L (Wu et al., 1998) , TRAF1, TRAF2, c-IAP-1 and c-IAP-2 (Wang et al., 1998) and (2) interference of apoptotic pathway by protein-protein interaction. However, protein levels of TRAF-2, c-IAP-1 and c-IAP-2 were not elevated in MIA PaCa-2 cells after stimulation with IL-1b for 24 h (data not shown). Therefore, it is not clear whether these anti-apoptotic proteins also play a role in the anti-apoptotic action of NF-kB. Since the highly stable form of IkB (IkBaDN) could block the anti-apoptotic action of NF-kB (Figure 5 ), yet NF-kB decoy could not block this action of NF-kB, it is possible that the activated NF-kB interacts with a pro-apoptotic protein such as 53BP2 Mori et al., 2000) and inhibits apoptosis. However, these two distinct mechanisms are not mutually exclusive since either mechanism alone cannot fully explain the antiapoptotic action of NF-kB.
Our present ®ndings indicate that biochemical as well as genetic intervention of NF-kB activation could be a rational strategy in order to sensitize cancer cells to the apoptosis induced by various anti-cancer agents. There have been a number of reports demonstrating the eective inhibition of NF-kB by small molecular weight compounds including sodium salicylate (Kopp and Ghosh, 1994) , glucocorticoids (Marx, 1995) , a kinase inhibitor fasudil hydrochloride (Sato et al., 1998) , an anti-rheumatic compound aurothioglucose (Yoshida et al., 1999; Traber et al., 1999) , and several antioxidants (Sakurada et al., 1996; Saliou et al., 1999) . Use of these compounds and derivatives is expected to augment the therapeutic ecacy of conventional cancer therapy.
Materials and methods
Reagents
Human recombinant cytokines IL-1b and TNF-a (Boehringer Mannheim, Mannheim, Germany), Hoechst-33258 (Molecular Probes, Eugene, OR, USA), CHX and propidium iodide (Sigma Chemical Co., St. Louis, MO, USA) were purchased from individual suppliers. Anti-IkB-a C-terminal (IkB-a (C-21)) and anti-His-tag (Omni-probe (M-21)) antibodies were purchased from Santa Cruz (Santa Cruz, CA, USA). 
Plasmid constructs
A deletion mutant of IkBa encoding amino acids 37 ± 317 (IkBaDN) was constructed as described previously (Brockman et al., 1995) . This truncated cDNA fragment was subcloned into the BamHI and NotI sites of pcDNA3.1/His B (Invitrogen, Carlsbad, CA, USA). The reporter plasmid expressing ®re¯y luciferase under the control of NF-kB (pGL3-4kBwt-Luc) was constructed by inserting four tandem copies of the kB sequence (GGGACTTTCC) from HIV-1 enhancer into pGL3-promoter vector (Promega, Madison, WI, USA) as reported previously (Sato et al., 1998) .
Cell culture
A human pancreatic cancer cell line MIA PaCa-2 was grown in Eagle's minimal essential medium supplemented with nonessential amino acids, 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomcyin. Another human pancreatic cancer cell line Capan-2 was grown in Dulbecco's modi®ed Eagle's medium with 1 mM glutamate, 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. Stable MIA PaCa-2 cells expressing IkBDN were selected as follows: Cells were transfected with plasmid pcDNA3.1-IkBDN using SuperFect (QIAGEN, Hiden, Germany) transfection reagent. Three days after transfection, the transfected cells were harvested and subjected to limiting dilution for cell cloning. Stable transfectants were selected in culture medium containing 800 mg/ml G418 (geneticin; GIBCO ± BRL, Rockville, MD, USA). Expression of IkBDN was con®rmed by Western blot analysis using either anti-IkBa C-terminal or anti-His-tag antibodies.
Evaluation of apoptosis
Quantitation of apoptosis was performed using FACScan (Becton Dickinson, San Jose, CA, USA) according to the Figure 5 Anti-apoptotic eects of NF-kB in the absence of de novo protein synthesis. Experiments were performed similarly as in Figure 3d . (a) Flow cytometric analyses of apoptosis. Cells were treated with TNF-a (100 ng/ml) for 4 h after pretreatment with IL-1b (20 ng/ml) for 2 h in the presence of CHX (5.0 mg/ml) which was added 1 h before addition of IL-1b. Control cells (Cont.) were incubated with medium alone. For comparison, the cytometric pro®le of the control experiment is overlaid by dotted lines. Note the appearance of G0/G1 peak in ME1 and parental cells, and its disappearance in MDN5 under the treatment of CHX+IL-1+TNF. (b) Quantitation of the number of apoptotic cells in (a). Data are means of ®ve independent experiments; bars, SD (n=5). Dierences between means were evaluated by the twotailed Student's t-test as indicated by an asterisk (*, P50.01) method of Nicoletti et al. (1991) . Brie¯y, cells were plated and cultured in 60 mm dishes to about 80% con¯uency, treated with TNF-a for 4 h, harvested by trypsinization, suspended in 70% chilled ethanol for ®xation, stained with 50 mg/ml propidium iodide (PI) in the presence of RNase A (20 mg/ml), and analysed for cell cycle distribution. The fraction of apoptotic cells was quantitated by counting the sub-G1 cells using CellQuest software (Becton Dickinson, San Jose, CA, USA). The apoptotic cells were also identi®ed by their fragmented and/or condensed nuclear morphology as revealed by the Hoechst-33258 staining upon¯uorescent microscopic examination.
Transfection and luciferase assay MIA PaCa-2 cells were grown in six well plates. After 2 days cells were transfected with plasmids using SuperFect transfection reagent. For each transfection, 40 ng of pGL3-4kBwt-Luc and 100 ng of internal control plasmid pRL-TK, expressing Renilla luciferase, were used. Transfected cells were cultured for 40 h and then further incubated for 24 h with or without 1.0 ng/ml TNF-a or 20 ng/ml IL-1b. Luciferase activities were measured using a commercial kit (Promega, Madison, WI, USA) with a Lumat model LB9507 luminometer (Berthold, Berlin, Germany) as described (Sato et al., 1998) . Experiments were carried out in triplicate and repeated at least three times.
Immunostaining
Semicon¯uent MIA PaCa-2 cells on Lab-Tek tissue culture chamber slides (Nunc, Inc., Naperville, IL, USA) were ®xed with 4.5% paraformaldehyde in phosphate-buered saline (PBS) for 15 min at room temperature, rinsed twice with PBS, and incubated with PBS containing 0.5% Triton X-100 for 20 min at room temperature. They were subsequently incubated with the primary anti-p65 rabbit antibody (C-20, Santa Cruz Biotechnology, Santa Cruz, CA, USA) for 1 h at 378C, rinsed three times with PBS containing 0.05% Triton X-100, and incubated with the secondary antibody,¯uor-escein-conjugated rabbit anti-mouse IgG (CAPPEL; ICN Pharmaceuticals, Aurora, OH, USA), for 1 h at 378C. The slides were rinsed three times with PBS and mounted with buered glycerol for¯uorescent microscopic examination. Primary and secondary antibodies were diluted at 1 : 1000 in PBS containing 3% bovine serum albumin.
Measurement of protein synthesis
Cells were cultured in 60 mm-diameter tissue culture dishes to 80% con¯uency. They were treated with or without CHX for 1 h, after which the cells were pulse-labeled for 2 h with 20 mCi of [ 3 H]leucine. After washing with PBS, the labeled cells were scraped and suspended in 10% trichloracetic acid containing 0.05 mg/ml bovine serum albumin and 0.01% NaN 3 . The suspension was ®ltered through a ®ltration apparatus onto glass micro®ber disks. The disks were washed twice with 5 ml ice-cold 10% TCA and twice with 5 ml 100% ethanol and then air-dried. The radioactivity in the disks was counted in a liquid scintillation spectrometer.
